Skip to main content

Publisher: Wiley-Blackwell

Volume 13, Number 12, 1 December 2011

Does intentional weight loss reduce cancer risk?
pp. 1063-1072(10)
Authors: Byers, T.; Sedjo, R. L.


Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
pp. 1073-1087(15)
Authors: Rensing, K. L.; Reuwer, A. Q.; Arsenault, B. J.; von der Thüsen, J. H.; Hoekstra, J. B. L.; Kastelein, J. J. P.; Twickler, Th. B.


Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide
pp. 1105-1113(9)
Authors: Mack, C. M.; Smith, P. A.; Athanacio, J. R.; Xu, K.; Wilson, J. K.; Reynolds, J. M.; Jodka, C. M.; Lu, M. G. W.; Parkes, D. G.


Tigerinin‐1R: a potent, non‐toxic insulin‐releasing peptide isolated from the skin of the Asian frog,
pp. 1114-1122(9)
Authors: Ojo, O. O.; Abdel‐Wahab, Y. H. A.; Flatt, P. R.; Mechkarska, M.; Conlon, J. M.


Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats
pp. 1123-1129(7)
Authors: Zhao, M.; Li, Y.; Wang, J.; Ebihara, K.; Rong, X.; Hosoda, K.; Tomita, T.; Nakao, K.


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more